N-acetyl cysteine as an osteogenesis-enhancing molecule for bone regeneration

Biomaterials

Volumn 34, Issue 26, 2013, Pages 6147-6156

  Yamada, Masahiro ^a,b   Tsukimura, Naoki ^a   Ikeda, Takayuki ^a   Sugita, Yoshihiko ^a   Att, Wael ^a,c   Kojima, Norinaga ^a   Kubo, Katsutoshi ^a   Ueno, Takeshi ^a   Sakurai, Kaoru ^b   Ogawa, Takahiro ^a  

^a UCLA SCHOOL OF DENTISTRY   (United States)

^b TOKYO DENTAL COLLEGE   (Japan)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Anti oxidant; Chemical biology; Growth factor; Multi function; Osteostimulation

Indexed keywords

ALKALINE PHOSPHATASE ACTIVITY; CHEMICAL BIOLOGY; GROWTH FACTOR; HISTOLOGICAL OBSERVATIONS; MULTI-FUNCTIONS; OSTEOBLASTIC CELLS; OSTEOBLASTIC DIFFERENTIATION; OSTEOSTIMULATION;

AMINO ACIDS; BONE; CELL CULTURE; COMPUTERIZED TOMOGRAPHY; DEFECTS; PHOSPHATASES;

MOLECULES;

ACETYLCYSTEINE; ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; DEXAMETHASONE; OSTEOCALCIN; OSTEOPONTIN;

ACCELERATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE MATRIX; BONE MINERALIZATION; BONE REGENERATION; CELL CULTURE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMUR; HEALING; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; MALE; MARKER GENE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STROMA CELL; UPREGULATION;

ACETYLCYSTEINE; ALKALINE PHOSPHATASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BONE MARROW CELLS; BONE REGENERATION; CELL SURVIVAL; CELLS, CULTURED; DEXAMETHASONE; FEMUR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; OSTEOBLASTS; OSTEOGENESIS; RATS; RATS, SPRAGUE-DAWLEY; STROMAL CELLS;

RATTUS;

EID: 84878628955     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.04.064     Document Type: Article

References (45)

1. Xu Y., Shi Y., Ding S. Achemical approach to stem-cell biology and regenerative medicine. Nature 2008, 453:338-344.
2. Emre N., Coleman R., Ding S. Achemical approach to stem cell biology. Curr Opin Chem Biol 2007, 11:252-258.
3. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
4. Shen A. Allosteric regulation of protease activity by small molecules. Mol Biosyst. 6:1431-43.
5. Lampson M.A., Kapoor T.M. Targeting protein stability with a small molecule. Cell 2006, 126:827-829.
6. Eke I., Leonhardt F., Storch K., Hehlgans S., Cordes N. The small molecule inhibitor QLT0267 radiosensitizes squamous cell carcinoma cells of the head and neck. PLoS One 2009, 4:e6434.
7. Idris A.I., Krishnan M., Simic P., Landao-Bassonga E., Mollat P., Vukicevic S., et al. Small molecule inhibitors of IkappaB kinase signaling inhibit osteoclast formation invitro and prevent ovariectomy-induced bone loss invivo. FASEB J 2010, 24:4545-4555.
8. Lee G.T., Hong J.H., Mueller T.J., Watson J.A., Kwak C., Sheen Y.Y., et al. Effect of IN-1130, a small molecule inhibitor of transforming growth factor-beta type I receptor/activin receptor-like kinase-5, on prostate cancer cells. JUrol 2008, 180:2660-2667.
9. Egusa H., Kaneda Y., Akashi Y., Hamada Y., Matsumoto T., Saeki M., et al. Enhanced bone regeneration via multimodal actions of synthetic peptide SVVYGLR on osteoprogenitors and osteoclasts. Biomaterials 2009, 30:4676-4686.
10. Yamada M., Ishihara K., Ogawa T., Sakurai K. The inhibition of infection by wound pathogens on scaffold in tissue-forming process using N-acetyl cysteine. Biomaterials 2011, 32:8474-8485.
11. Minamikawa H., Yamada M., Deyama Y., Suzuki K., Kaga M., Yawaka Y., et al. Effect of N-acetylcysteine on rat dental pulp cells cultured on mineral trioxide aggregate. JEndod 2011, 37:637-641.
12. Yamada M., Kojima N., Att W., Minamikawa H., Sakurai K., Ogawa T. Improvement in the osteoblastic cellular response to a commercial collagen membrane and demineralized freeze-dried bone by an amino acid derivative: an invitro study. Clin Oral Implants Res 2011, 22:165-172.
13. Yamada M., Minamikawa H., Ueno T., Sakurai K., Ogawa T. N-acetyl cysteine improves affinity of beta-tricalcium phosphate granules for cultured osteoblast-like cells. JBiomater Appl 2012, 27:27-36.
14. Yamada M., Kubo K., Ueno T., Iwasa F., Att W., Hori N., et al. Alleviation of commercial collagen sponge- and membrane-induced apoptosis and dysfunction in cultured osteoblasts by an amino acid derivative. Int J Oral Maxillofac Implants 2010, 25:939-946.
15. Minamikawa H., Yamada M., Iwasa F., Ueno T., Deyama Y., Suzuki K., et al. Amino acid derivative-mediated detoxification and functionalization of dual cure dental restorative material for dental pulp cell mineralization. Biomaterials 2010, 31:7213-7225.
16. Yamada M., Ueno T., Minamikawa H., Sato N., Iwasa F., Hori N., et al. N-acetyl cysteine alleviates cytotoxicity of bone substitute. JDent Res 2010, 89:411-416.
17. Sato N., Ueno T., Kubo K., Suzuki T., Tsukimura N., Att W., et al. N-Acetyl cysteine (NAC) inhibits proliferation, collagen gene transcription, and redox stress in rat palatal mucosal cells. Dent Mater 2009, 25:1532-1540.
18. Tsukimura N., Yamada M., Aita H., Hori N., Yoshino F., Chang-Il Lee M., et al. N-acetyl cysteine (NAC)-mediated detoxification and functionalization of poly(methyl methacrylate) bone cement. Biomaterials 2009, 30:3378-3389.
19. Yamada M., Kojima N., Att W., Hori N., Suzuki T., Ogawa T. N-Acetyl cysteine restores viability and function of rat odontoblast-like cells impaired by polymethylmethacrylate dental resin extract. Redox Rep 2009, 14:13-22.
20. Att W., Yamada M., Kojima N., Ogawa T. N-Acetyl cysteine prevents suppression of oral fibroblast function on poly(methylmethacrylate) resin. Acta Biomater 2009, 5:391-398.
21. Kojima N., Yamada M., Paranjpe A., Tsukimura N., Kubo K., Jewett A., et al. Restored viability and function of dental pulp cells on poly-methylmethacrylate (PMMA)-based dental resin supplemented with N-acetyl cysteine (NAC). Dent Mater 2008, 24:1686-1693.
22. Yamada M., Kojima N., Paranjpe A., Att W., Aita H., Jewett A., et al. N-acetyl cysteine (NAC)-assisted detoxification of PMMA resin. JDent Res 2008, 87:372-377.
23. Parasassi T., Brunelli R., Bracci-Laudiero L., Greco G., Gustafsson A.C., Krasnowska E.K., et al. Differentiation of normal and cancer cells induced by sulfhydryl reduction: biochemical and molecular mechanisms. Cell Death Differ 2005, 12:1285-1296.
24. Gustafsson A.C., Kupershmidt I., Edlundh-Rose E., Greco G., Serafino A., Krasnowska E.K., et al. Global gene expression analysis in time series following N-acetyl L-cysteine induced epithelial differentiation of human normal and cancer cells invitro. BMC Cancer 2005, 5:75.
25. Paranjpe A., Cacalano N.A., Hume W.R., Jewett A. N-acetylcysteine protects dental pulp stromal cells from HEMA-induced apoptosis by inducing differentiation of the cells. Free Radic Biol Med 2007, 43:1394-1408.
26. Jun J.H., Lee S.H., Kwak H.B., Lee Z.H., Seo S.B., Woo K.M., et al. N-acetylcysteine stimulates osteoblastic differentiation of mouse calvarial cells. JCell Biochem 2008, 103:1246-1255.
27. Saruwatari L., Aita H., Butz F., Nakamura H.K., Ouyang J., Yang Y., et al. Osteoblasts generate harder, stiffer, and more delamination-resistant mineralized tissue on titanium than on polystyrene, associated with distinct tissue micro- and ultrastructure. JBone Miner Res 2005, 20:2002-2016.
28. Takeuchi K., Saruwatari L., Nakamura H.K., Yang J.M., Ogawa T. Enhanced intrinsic biomechanical properties of osteoblastic mineralized tissue on roughened titanium surface. JBiomed Mater Res A 2005, 72:296-305.
29. Butz F., Ogawa T., Chang T.L., Nishimura I. Three-dimensional bone-implant integration profiling using micro-computed tomography. Int J Oral Maxillofac Implants 2006, 21:687-695.
30. Malaval L., Liu F., Roche P., Aubin J.E. Kinetics of osteoprogenitor proliferation and osteoblast differentiation invitro. JCell Biochem 1999, 74:616-627.
31. Stein G.S., Lian J.B., Owen T.A. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 1990, 4:3111-3123.
32. Koide M., Osaki K., Konishi J., Oyamada K., Katakura T., Takahashi A., et al. Anew type of biomaterial for artificial skin: dehydrothermally cross-linked composites of fibrillar and denatured collagens. JBiomed Mater Res 1993, 27:79-87.
33. Stein G.S., Lian J.B., van Wijnen A.J., Stein J.L., Montecino M., Javed A., et al. Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene 2004, 23:4315-4329.
34. Komori T. Regulation of osteoblast differentiation by transcription factors. JCell Biochem 2006, 99:1233-1239.
35. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997, 89:747-754.
36. Tsuji K., Bandyopadhyay A., Harfe B.D., Cox K., Kakar S., Gerstenfeld L., et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 2006, 38:1424-1429.
37. Nakase T., Nomura S., Yoshikawa H., Hashimoto J., Hirota S., Kitamura Y., et al. Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. JBone Miner Res 1994, 9:651-659.
38. Onishi T., Ishidou Y., Nagamine T., Yone K., Imamura T., Kato M., et al. Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats. Bone 1998, 22:605-612.
39. Bostrom M.P., Lane J.M., Berberian W.S., Missri A.A., Tomin E., Weiland A., et al. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. JOrthop Res 1995, 13:357-367.
40. Dimitriou R., Tsiridis E., Giannoudis P.V. Current concepts of molecular aspects of bone healing. Injury 2005, 36:1392-1404.
41. Lee K.S., Kim H.J., Li Q.L., Chi X.Z., Ueta C., Komori T., et al. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 2000, 20:8783-8792.
42. Zhang Y.W., Yasui N., Ito K., Huang G., Fujii M., Hanai J., et al. ARUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci U S A 2000, 97:10549-10554.
43. Ueno T., Yamada M., Sugita Y., Ogawa T. N-acetyl cysteine protects TMJ chondrocytes from oxidative stress. JDent Res 2011, 90:353-359.
44. Aita H., Tsukimura N., Yamada M., Hori N., Kubo K., Sato N., et al. N-acetyl cysteine prevents polymethyl methacrylate bone cement extract-induced cell death and functional suppression of rat primary osteoblasts. JBiomed Mater Res A 2010, 92:285-296.
45. Yamada M., Ogawa T. Chemodynamics underlying N-acetyl cysteine-mediated bone cement monomer detoxification. Acta Biomater 2009, 5:2963-2973.